Home » Newsletters » BioWorld Science

BioWorld Science

July 12, 2022

View Archived Issues

PLK4 inhibitor with promising preclinical activity against TRIM37-amplified breast cancer

Murine model resembles cardiovascular disease seen in NAFLD

Medshine Discovery patents compounds for fungal infections

Chiesi Farmaceutici discloses new ROCK inhibitors

UCB SA divulges new DRD1 PAMs

Roche presents new Raf kinase B inhibitors

Chengdu Baiyu Pharmaceutical identifies new LANCL2 activators

SBP-101 modulates polyamine metabolism and shows efficacy in ovarian cancer models

Novel murine models of diet-induced NASH developed

RS BioTherapeutics reports findings on RSBT-001 in mouse model of pulmonary inflammation

MIF/CD74 axis identified as a critical determinant of TME composition in sarcoma

iNtRON Biotechnology reports efficacy of CDL-200 against clinical isolates from CDI patients

PARP/SIK2 inhibition shows potential for treating ovarian cancer and TNBC

Tenaya sets out rationale for targeting HDAC6 in heart failure

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...